RE
REGN
Mar 31, 2023
Quarter ended Mar 31, 2023 · FY2023 Q1

Regeneron Pharmaceuticals, Inc. stock research

Regeneron Pharmaceuticals (REGN) Free Cash Flow — Quarter Ended Mar 31, 2023

Revenue and operating cash flow both decreased from the prior quarter and from the same quarter last year. Free cash flow margin weakened compared with both periods.

Free cash flow takeaway

A quick read on the company's cash generation and what it means for investors.

Revenue and operating cash flow both decreased from the prior quarter and from the same quarter last year. Free cash flow margin weakened compared with both periods.

  • Operating cash flow as a proportion of revenue was lower than the prior quarter and significantly lower than a year ago. Capital expenditure was higher than both comparison periods, further reducing free cash flow and margin.
  • Compared with the immediately preceding quarter, revenue, operating cash flow, free cash flow, and free cash flow margin all declined. Versus the same quarter one year earlier, all metrics were lower except capital expenditure, which was higher.

FCF snapshot

Quarterly and TTM cash-flow metrics with the minimum valuation context.

TTM free cash flow

$3.7B

Trailing twelve-month free cash flow.

Quarter free cash flow

$1.2B

Free cash flow in the selected fiscal quarter.

Operating cash flow

$1.4B

Cash generated by operations before capital spending.

CapEx

$178.2M

Capital spending and related asset purchases.

FCF margin

37.6%

The share of revenue converted into free cash flow.

Cash flow trend

A short quarterly history shows whether FCF is scaling with revenue or only spiking for one period.

PeriodRevenueOperating CFCapExFCFFCF margin
2022-06-30$2.9B$564.4M$153.6M$410.8M14.4%
2022-09-30$2.9B$628.9M$142.5M$486.4M16.6%
2022-12-31$3.4B$1.7B$152.2M$1.6B45.9%
2023-03-31$3.2B$1.4B$178.2M$1.2B37.6%

Cash conversion quality

Checks that separate high-quality free cash flow from accounting noise or working-capital timing.

FCF / net income145.4%Shows whether accounting earnings convert into cash.
CapEx / revenue5.6%Lower capital intensity usually supports FCF margin.
Net cashn/aCash and equivalents minus total debt.

Recent events shaping cash flow

Near-term business events that help explain the free cash flow result.

Watch

Operating Cash Flow Decline

Operating cash flow was lower than both the prior quarter and the same quarter last year, while capital expenditure increased. This combination drove free cash flow and margin lower.

The decline in operating cash flow was the strongest observable factor reducing free cash flow.

What the cash flow says

How to interpret the company's free cash flow beyond the headline number.

Operating cash flow as a proportion of revenue was lower than the prior quarter and significantly lower than a year ago. Capital expenditure was higher than both comparison periods, further reducing free cash flow and margin.

Compared with the immediately preceding quarter, revenue, operating cash flow, free cash flow, and free cash flow margin all declined. Versus the same quarter one year earlier, all metrics were lower except capital expenditure, which was higher.

Monitor the trajectory of operating cash flow, as it declined from both the prior quarter and the year-ago quarter.